GAB2 and liver cancer: Here, two miRNAs—miR-9 and miR-181a—were found to target Gab2 that inhibit the migration and proliferation of HepG2 cells, providing a novel potential method to prevent and treat liver diseases, including chronic diseases and cancers of the liver.